Table 3 Effects of increasing dietary fibre intakes on cardiometabolic risk factors in patients with established hypertension
Outcome | Trial arms | Participants (I/C) | Initial I2 | MD (95% CI) | Grade |
|---|---|---|---|---|---|
Systolic blood pressure (mmHg) | 9 | 281/250 | 99% | − 4.3 (− 5.8 to − 2.8) | High |
Diastolic blood pressure (mmHg) | 9 | 281/250 | 99% | − 3.1 (− 4.4 to − 1.7) | High |
Total cholesterol (mmol/L) | 5 | 190/144 | 98% | − 0.22 (− 0.45 to 0.01) | Low |
LDL cholesterol (mmol/L) | 3 | 137/88 | 97% | − 0.29 (− 0.40 to − 0.17) | Low |
HDL cholesterol (mmol/L) | 4 | 169/119 | 93% | 0.02 (− 0.01 to 0.05) | Low |
Triglycerides (mmol/L) | 4 | 169/119 | 99% | − 0.19 (− 0.30 to − 0.08) | Low |
Body weight (kg) | 3 | 137/88 | 99% | − 0.14 (− 1.36 to 1.08) | Low |
BMI (kg/m2) | 2 | 92/45 | 99% | − 1.3 (− 2.1 to − 0.5) | Low |
HbA1c (%) | 1 | 32/31 | - | 0.3 (0.20 to 0.40) | Very low |
Fasting plasma glucose (mmol/L) | 5 | 195/153 | 99% | − 0.48 (− 0.91 to − 0.05) | Moderate |
Fasting plasma insulin (pmol/L) | 4 | 150/110 | 97% | − 3.5 (− 5.5 to − 1.6) | Low |